- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04978064
E-health Psychological Intervention in Pregnant Women Exposed to Intimate Partner Violence (eIPV) (eIPV)
E-health Psychological Intervention in Pregnant Women Exposed to Intimate Partner Violence (eIPV): a Pilot Randomised Controlled Trial
The investigators will assess the need and feasibility of randomising a sufficiently large number of women exposed to IPV during pregnancy in a full-scale future randomised trial. To achieve this, the investigators will:
- estimate rates of consent to randomization, and the rates of adherence and dropout following randomization (for the use in sample size estimation)
- determine recruitment duration
- examine the women's perception about the benefit of the intervention
- determine the reasons for acceptability, non-adherence, and obstacles to recruitment, randomisation and consent through qualitative interviews
Study Overview
Status
Intervention / Treatment
Detailed Description
Introduction. Intimate partner violence (IPV) during pregnancy, a condition as common as obstetrics conditions like gestational diabetes, is associated with maternal and neonatal complications. Systematic detection of IPV is not well established in antenatal screening probably because the effectiveness of protective interventions has not been evaluated. Among mothers exposed to IPV, e-health interventions during pregnancy may be beneficial. Prior to performing a full-scale effectiveness trial for such an intervention, a pilot study is required to assess the need and feasibility of randomising a sufficiently large number of women at exposed to IPV during pregnancy.
Methods. The eIPV trial is a randomised pilot study nested within a cohort of consenting mothers at <12 weeks' gestation who screen positive for IPV in the first antenatal visit and accept an e-health package (psychological counselling by videoconference) in Spain and Denmark. Twenty eligible mothers from the above cohort will be randomised to either intervention or control. The intervention group will receive the e-health package as part of the cohort. The control group will be invited to accept a delay in the intervention (e-health package eight weeks later). After consenting to delay, the control group will provide comparative data without losing the opportunity of obtaining the intervention. The investigators will determine estimates of rates of informed consent to randomization, and the rates of adherence and dropout following randomization. Qualitative interviews will be conducted to examine the women's perception about the benefit of the intervention, reasons for acceptability and non-adherence, and obstacles to recruitment, randomisation and consent. The results will inform the feasibility and variance of key clinical outcome measures for estimation of sample size of the full-scale effectiveness trial.
Comment. The pilot study nested within the cohort study will allow us to obtain information about the rates of IPV in pregnancy, the acceptability of an e-health intervention and the availability of participants for randomisation into a large effectiveness trial.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
• Pregnant women at <12 weeks gestation, who screen positive in IPV at the first antenatal visit and accept the e-health package.
Exclusion Criteria:
- Women who cannot be informed about the study without their partners or other family members knowing
- Women mentally or physically incapacity to participate in the study
- Women below 16 years in Spain or below 18 years in Denmark
- Inability to understand Danish/Spanish
- Lack of internet and electronic device
- Women with extreme severity of IPV. Women selected to participate in the trial in this situation will receive a danger assessment before randomisation and if the severity of IPV is confirmed, they will be routinely treated and supported according to the standard protocol in each country. Women who have same-sex partners will be screened, but their data will not be used for the purpose of this study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Behavioral e-health psychological counselling
|
Intervention group: Women positive for IPV who accept the e-Health intervention and who have been randomly allocated in the intervention group will receive the e-health package as the rest of the cohort, as well as the baseline and outcome measurements. The e-health package will include six video counselling sessions by trained providers and the access to a mobile application for designing security plans, an adapted version of the mobile application "My Plan". The content of the six individually tailored sessions will be based on the Dutton's Empowerment Model and the Psychosocial Readiness Model. Control group: women positive in IPV who accept the e-Health intervention package will be asked for a second consent to receive a delayed intervention (8 weeks later) and to complete as the baseline and outcome measurements. Women can request to leave the control group at any time and to receive the intervention immediately (in which case they data will be part of the cohort study). |
Other: Control group
Usual care (delayed behavioral e-health psychological counselling)
|
Intervention group: Women positive for IPV who accept the e-Health intervention and who have been randomly allocated in the intervention group will receive the e-health package as the rest of the cohort, as well as the baseline and outcome measurements. The e-health package will include six video counselling sessions by trained providers and the access to a mobile application for designing security plans, an adapted version of the mobile application "My Plan". The content of the six individually tailored sessions will be based on the Dutton's Empowerment Model and the Psychosocial Readiness Model. Control group: women positive in IPV who accept the e-Health intervention package will be asked for a second consent to receive a delayed intervention (8 weeks later) and to complete as the baseline and outcome measurements. Women can request to leave the control group at any time and to receive the intervention immediately (in which case they data will be part of the cohort study). |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Consent rate for a future full-scale RCT trial
Time Frame: Three to nine months
|
Rate of women who were positive in IPV, consent to receive e-health package and consent to randomization in the control group.
|
Three to nine months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Positivity rate of the cohort study (useful for planning the future full-scale randomised control trial):
Time Frame: Three to nine months
|
Rate of women who were positive in IPV and consent to receive e-health package
|
Three to nine months
|
Completion rate in the intervention group a future full-scale RCT trial
Time Frame: Three to nine months
|
Rate of women who were recruited to intervention group, and for whom complete outcomes were obtained.
|
Three to nine months
|
Completion rate in the control group a future full-scale RCT trial
Time Frame: Three to nine months
|
Rate of women who were recruited to control group, and for whom complete outcomes were obtained.
|
Three to nine months
|
Recruitment duration for a future full-scale RCT trial
Time Frame: Three to nine months
|
Recruitment duration (in days) to get the pilot sample (5 women for the intervention group and 5 women for the control group, in each country)
|
Three to nine months
|
Benefit of the intervention a future full-scale RCT trial
Time Frame: Three to nine months
|
Perception of the intervention by women participating in the pilot through the information obtained in qualitative interviews.
|
Three to nine months
|
Perception about the delay of the intervention of the control group for a future full-scale RCT trial
Time Frame: Three to nine months
|
Perception about the duration of delay of the intervention of women in the control group (provided in the qualitative interviews).
|
Three to nine months
|
Reasons for acceptability, non-adherence, and obstacles for a future full-scale RCT trial
Time Frame: Three to nine months
|
Reasons for acceptability, non-adherence, and obstacles to recruitment, randomization, consent and follow-up (provided in the qualitative interviews).
|
Three to nine months
|
Follow up rate for a future full-scale RCT trial
Time Frame: Three to nine months
|
Rate of failure to obtain data in the follow-up.
|
Three to nine months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Khalid S. Khan, Universidad de Granada
Publications and helpful links
General Publications
- Martin-de-Las-Heras S, Velasco C, Luna-Del-Castillo JD, Khan KS. Breastfeeding avoidance following psychological intimate partner violence during pregnancy: a cohort study and multivariate analysis. BJOG. 2019 May;126(6):778-783. doi: 10.1111/1471-0528.15592. Epub 2019 Jan 24.
- Roman-Galvez RM, Martin-Pelaez S, Martinez-Galiano JM, Khan KS, Bueno-Cavanillas A. Prevalence of Intimate Partner Violence in Pregnancy: An Umbrella Review. Int J Environ Res Public Health. 2021 Jan 15;18(2):707. doi: 10.3390/ijerph18020707.
- Rasch V, Van TN, Nguyen HTT, Manongi R, Mushi D, Meyrowitsch DW, Gammeltoft T, Wu CS. Intimate partner violence (IPV): The validity of an IPV screening instrument utilized among pregnant women in Tanzania and Vietnam. PLoS One. 2018 Feb 1;13(2):e0190856. doi: 10.1371/journal.pone.0190856. eCollection 2018.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- eIPV
- 202167133116 (Other Identifier: Andalusian Research Ethics Committee)
- 20212000-80 (Other Identifier: Regional Committees Health Research Ethics Southern Denmark)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Study Protocol
- Informed Consent Form (ICF)
- Clinical Study Report (CSR)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Related
-
4YouandMeCambridge Cognition Ltd; Sema4; Evidation Health; Vector Institute of Artificial... and other collaboratorsCompletedPregnancy Related | Wearables | Pregnancy EarlyUnited States
-
Helen Keller InternationalEleanor Crook FoundationNot yet recruitingPregnancy Related | Supplementation | Postnatal Related
-
The University of Texas Health Science Center,...CompletedPregnancy Related | Pregnancy, High RiskUnited States
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
University of CopenhagenStanford UniversityRecruitingPregnancy RelatedDenmark
-
European Vaccine InitiativeKintampo Health Research Centre, Ghana; Groupe de Recherche Action en Sante; Fondation... and other collaboratorsRecruitingPregnancy RelatedBenin, Burkina Faso, Ghana, Malawi
-
Kahramanmaras Sutcu Imam UniversityNot yet recruitingPregnancy RelatedTurkey
-
Fondation Hôpital Saint-JosephRecruiting
-
German Institute of Human NutritionRecruiting
-
Kahramanmaras Sutcu Imam UniversityRecruiting
Clinical Trials on e-health psychological counselling
-
University of Campania "Luigi Vanvitelli"RecruitingPsychological Distress | Psychological Intervention | University StudentsItaly
-
Shenzhen Smoore Technology LimitedWithdrawn
-
Cukurova UniversityCompletedPatient Education | Bariatric Surgery | Mobile Application | CounsellingTurkey
-
Norwegian School of Sport SciencesNational Dairy CouncilCompletedDepression | Exercise Addiction | Perfectionism | Binge Eating | Body Image | Eating Disorder | Resting Metabolic Rate | Dietary Deficiency | Bone Mineral Density, Low, Susceptibility to | Exercise-Related Amenorrhea | Dietary AmenorrheaNorway
-
Yale UniversityCompletedObesity | Type 2 DiabetesUnited States
-
Kuopio University HospitalUniversity of Eastern FinlandCompleted
-
University of Southern DenmarkMunicipality of SønderborgCompleted
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR)CompletedColon Cancer | Colonic NeoplasmsCanada
-
Wei XIA, PhDNot yet recruitingMental Health IssueChina
-
University of NottinghamCompletedPsychological WellbeingUnited Kingdom